tbuckley/cabot-search huggingface dataset:
Link between Bone Marrow and Cardiac Iron Overload in Thalassemia Major
Authors: Antonella Meloni, Laura Pistoia, Gennaro Restaino, Massimiliano Missere, Vincenzo Positano, Rosamaria Rosso, Valentina Carrai, Domenico Maddaloni, Luciana Rigoli, Monica Benni, Crocetta Argento, Domenico Visceglie, Aurelio Maggio, Filippo Cademartiri
Journal: Blood (2022)
Feasibility and Improvement in Survival with a Risk-Adapted Treatment Regimen for Childhood Acute Lymphoblastic Leukemia in a Limited Resource Setting
Authors: Yajaira Valentine Jimenez-Antolinez, Samantha Fierro Sáenz, Lilia Edith Carrizales Torres, Julia Esther Colunga Pedraza, Hernan Ramirez-Duran, Andrés Gómez-De León, David Gómez-Almaguer, Oscar Gonzalez
Journal: Blood (2022)
The Position of MYC Rearrangements in the Genomic Landscape of Diffuse Large B-Cell Lymphoma
Authors: Erik Van Dijk, Jurriaan Janssen, Matias Mendeville, G. Tjitske Los-De Vries, Margaretha GM Roemer, Phylicia Stathi, Julia Richter, Yong Soo Kim, Wolfram Klapper, Ulrich Dührsen, Andreas Hüttmann, P. J Lugtenburg, Josée M. Zijlstra, Marie Jose Kersten, Daphne de Jong, Martine E.D. Chamuleau, Bauke Ylstra
Journal: Blood (2022)
Pediatrics Non-Hodgkin's Lymphoma Survivors: Should We Worry about Quality of Life and Late Therapy Effects?
Authors: Azza Ali Fahmy Ayad, Reham Abdelaziz Khedr, Asmaa Mohammed Hamoda, Tamer Diab, Nahla Elnabarawy, Elhamy Rifky, Leslie E. Lehmann, Alaa M. Elhaddad
Journal: Blood (2022)
Disruption of Intracellular Metal Homeostasis As a Vulnerability in <i>SF3B1</i> Mutated AML
Authors: Céline Moison, Deanne Gracias, Julie Schmitt, Simon Girard, Simon Fortier, Isabel Boivin, Jean-Francois Spinella, Tara Macrae, Rejean Ruel, Josee Hebert, Anne Marinier, Guy Sauvageau
Journal: Blood (2022)
A First-in-Human Phase 1 Study of Abbv-319, an Antibody-Drug Conjugate Composed of a CD19 Antibody Linked to a Potent Proprietary Glucocorticoid Receptor Modulator, in Patients with Relapsed or Refractory B-Cell Malignancies
Authors: Moshe Levy, Carl Gustafson, James Purcell, Kevin J. Freise, Wissam Assaily, Deanna Brackman, William R. Henner, Michael McDevitt, John Kuruvilla
Journal: Blood (2022)
Clonotypic Mass Spectrometry with Easym Assay for Detection of Measurable Residual Disease in Multiple Myeloma
Authors: Michael J Slade, Abir Khalid, Mark A Fiala, Mariya Liyasova, Mark A Zaydman, Zac McDonald, Julie M Fortier, Sarah Kelley, Zachary D. Crees, Mark A. Schroeder, Keith E Stockerl-Goldstein, Liqiang Yang, Ravi Vij
Journal: Blood (2022)
Zanubrutinib, Lenalidomide, Rituximab, Temozolomide and Methotrexate (RLZT±MTX) As First-Line Treatment for Newly Diagnosed PCNSL: A Prospective, Open-Lable, Multicenter Clinical Trial
Authors: Jia Song, Hui Liu, Zongjiu Jiao, Da Gao, Kai Ding, Yihao Wang, Hong Yu, Yuanyuan Shao, Huijuan Jiang, Shan Gao, Lijuan Li, Rong Fu, Zonghong Shao
Journal: Blood (2022)
A Spanish Medical Record Review of Adults with Relapsed or Refractory CD30+ Malignancies When Re-Treated with Brentuximab Vedotin (BV): Preliminary Analysis of the Believe Study (NCT:04998331)
Authors: Anna Sureda, Lourdes Baeza, Andrea Naves, Jesús Aparicio, Ramón García-Sanz
Journal: Blood (2022)
Mivavotinib, a Syk Inhibitor, in Relapsed/Refractory (R/R) Non-GCB Diffuse Large B-Cell Lymphoma (DLBCL) with or without MYD88 and/or CD79 Mutations: A Phase 2 Study
Authors: Reem Karmali, Daniel J. Landsburg, Jason Westin, John P. Leonard, Emil T. Kuriakose, Bradley James Sumrow, Susheela Carroll, Katherine Albert, Lalith Akella, Leo I. Gordon
Journal: Blood (2022)
Magrolimab in Combination with Rituximab + Chemotherapy in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Authors: Joseph Maakaron, Adam S. Asch, Leslie L. Popplewell, Graham P. Collins, Ian W. Flinn, Nilanjan Ghosh, Colin Keane, Matthew Ku, Amitkumar Mehta, Mark Roschewski, Carol O'Hear, Xuehan Ren, Bertha Villa, Indu Lal, Sonali M. Smith, Ranjana H. Advani
Journal: Blood (2022)
Autologous Hematopoietic Stem Cell Transplantation Improves Survival in Patients with Multiple Myeloma and End Stage Renal Disease
Authors: Sandeep Anand Padala, Anusha Vakiti, Wendy Bollag, Jennifer Waller, Mufaddal Kheda, Stephanie L Baer, Ravindra Kolhe, Mohammad A.H. Mian, Anand P. Jillella, Jorge E. Cortes, Vamsi Kota
Journal: Blood (2022)
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma
Authors: Swetha Kambhampati, Matthew Mei, Lu Chen, Sandrine Puverel, Robert Chen, Leslie L. Popplewell, Liana Nikolaenko, Lacolle Peters, Saro H. Armenian, Larry W. Kwak, Steve T Rosen, Stephen J Forman, Alex F. Herrera
Journal: Blood (2022)
Evidence Gaps in the Management of Patients with Sickle Cell Disease (SCD) by Non-specialist Healthcare Professionals (HCPs): Results from the Real-World Assessment Survey for SCD in Saudi (ROARS)
Authors: Wasil Jastaniah, Abdullah Hasan Al Zayed, Hussain H. Al Saeed, Mohamed Al Darwish, Muneer Albagshi, Hafiz Malhan, Ahmad Tarawah, Aljawhara Al Manea, Iman Alhazmi, Mohamed Qari, Azzah Alzahrani, Mohsen Alzahrani, Wesam Soliman, Farid Askar, Sukina Almustafa, Hatoon M. Ezzat
Journal: Blood (2022)
Therapeutic Gene Editing of HSCs Ex Vivo without in Vitro Culture Avoids Genotoxicity, Simplifies Procedures, and Preserves Efficiency and Stemness
Authors: Jing Zeng, My Anh Nguyen, Marioara-Felicia Ciuculescu, Esther Mintzer, Pengpeng Liu, Linda Yingqi Lin, Tolulope O Rosanwo, Archana Verma, Nola Neri, Stacy A. Maitland, Alden Richter, David G. Justus, Kendell Clement, Christian Brendel, Luca Pinello, John P Manis, Myriam Armant, Scot A. Wolfe, Daniel E. Bauer
Journal: Blood (2022)
Outpatient Practice Pattern for Recently Approved CAR-T in Patients with Lymphoma and Multiple Myeloma
Authors: Radhika Bansal, Jonas Paludo, Matthew A. Hathcock, Megan T Spychalla, Arushi Khurana, Paul J. Hampel, Urshila Durani, Hassan B. Alkhateeb, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Yucai Wang, Saad S. Kenderian, Moritz Binder, Taxiarchis Kourelis, Shaji K Kumar, Mithun V. Shah, Rahma M Warsame, N. Nora Bennani, Morie A Gertz, Patrick B. Johnston, Stephen M. Ansell, Mustaqeem A. Siddiqui, Yi Lin
Journal: Blood (2022)
Efficacy and Safety of a Novel Non-Myeloablative Conditioning Regimen for Hematopoietic Cell Transplantation in Adults with Severe Aplastic Anemia
Authors: Rachel M Gilmore, Karin M Abernathy, Kendall C Shultes, Dwight D Eplin, Lindsay Orton, Adetola A. Kassim, Bipin N. Savani, Salyka M. Sengsayadeth, Brian G. Engelhardt, Wichai Chinratanalab, Tae Kon Kim, Bhagirathbhai Dholaria, Reena Jayani, Leena Choi, Elizabeth McNeer, Katie S. Gatwood
Journal: Blood (2022)
Gain of chr1q Portends Poor Outcomes in Multiple Myeloma Patients Treated with Venetoclax
Authors: Alessandro Lagana, Santiago Thibaud, David T. Melnekoff, Paula Restrepo, Violetta Leshchenko, Jonathan McCafferty, Scott Newman, Abbi Kern, David Corrigan, Feras Hantash, Adriana Rossi, Cesar Rodriguez, Larysa Sanchez, Shambavi Richard, Ajai Chari, Hearn J. Cho, Sundar Jagannath, Joshua Richter, Samir Parekh
Journal: Blood (2022)
Metaphyseal Stromal Progenitor Cells Are Skewed Via Wnt-Activation Towards Osteogenesis in Progressed Myelofibrosis
Authors: Bella Banjanin, James Nagai, Yevin Mun, Inge Snoeren, Stijn Fuchs, Marek Weiler, Fabian Kiessling, Twan Lammers, Kishor Sivaraj, Ralf Adams, Cesar Nombela-Arrieta, Ivan Costa, Rebekka K. Schneider
Journal: Blood (2022)
Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Authors: Huilai Zhang, Keshu Zhou, Ying Cheng, Liling Zhang, Haiyan Yang, Liqun Zou, Junning Cao, Huiqiang Huang, Ye Guo, Zhao Wang, Sha Huang, Zhiyu Liang, Hui Yao, Haiyi Guo, Yiqian Fang, Hongjie Zhu
Journal: Blood (2022)
Extracellular Vesicles from Sickle Red Blood Cells Activate Endothelial Cells and Trigger Von Willebrand Factor-Mediated Sickle Red Cell Adhesion
Authors: Ran An, Yuncheng Man, Kevin Cheng, Tianyi Zhang, Chunsheng Chen, Erdem Kucukal, William Wulftange, Utku Goreke, Allison Bode, Lalitha Nayak, Gregory M. Vercellotti, John D Belcher, Jane Alison Little, Umut A. Gurkan
Journal: Blood (2022)
Association of Immune Dynamics and Treatment Outcome in Patients (pts) with Relapsed/Refractory Non-Hodgkin Lymphoma (R/R NHL) Treated with the Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent CC-99282
Authors: Soraya Carrancio, Wen-Chi Chou, Alberto Risueño, Carla Guarinos, Gonzalo Lopez, Jean-Marie Michot, Loretta J. Nastoupil, Julio Chavez, Cecilia Carpio, Silvia Ferrari, Tatyana A. Feldman, Daniel Morillo Giles, Antonio Pinto, Danielle Greenawalt, Daniel W. Pierce, Michael Pourdehnad
Journal: Blood (2022)
Homoharringtonine Exhibits Anti-Tumor Effect in T-Cell Acute Lymphoblastic Leukemia By Targeting Notch1/Myc Pathway
Authors: Shanshan Suo, Dandan Zhao, Fenglin Li, Sonia Rodriguez, Junjing Qiao, Chen Liang, Le Xuan Truong Nguyen, Dinh Hoa Hoang, Fang Chen, Ivan Rodriguez, Lucy Ghoda, Tinisha McDonald, Ling Li, Nadia Carlesso, Bin Zhang, Guido Marcucci, Jie Jin
Journal: Blood (2022)
Fedratinib Induces Cytokine Changes Correlating with Clinical Response in Ruxolitinib Exposed Myelofibrosis Patients: Biomarker Analysis from the Freedom Trial
Authors: Danny V Jeyaraju, Sheida Hayati, Ann Polonskaia, Maryam Alapa, Manuel Ugidos, Andrew Browne, Alberto Risueño, Patrick Hagner, Vikas Gupta, Moshe Talpaz, Christopher Hernandez, Vincent Chia, Patricia Martin-Regueira, Daniel Lopes de Menezes, Ross La Motte-Mohs, Rajasekhar NVS Suragani, Anita K. Gandhi
Journal: Blood (2022)
Insulin Secretion and β-Cell Function Are Preserved in Patients with Treated Hematological Malignancies
Authors: Rahul Shah, J. Matthew Luther, Michael Byrne, Dae Kwang Jung, Salyka M. Sengsayadeth, Bhagirathbhai Dholaria, Adetola A. Kassim, Bipin N. Savani, Wichai Chinratanalab, Reena Jayani, Brian G. Engelhardt
Journal: Blood (2022)
Direct Comparison of NSG and NBSGW Mice for MDS Patient-Derived Xenograft Models
Authors: Nanni Schmitt, Alexander Streuer, Justine Danner, Eva Altrock, Vladimir Riabov, Qingyu Xu, Felicitas Rapp, Nadine Weimer, Iris Palme, Verena Nowak, Julia Obländer, Melda Göl, Ali Darwich, Laurenz Steiner, Tobias Boch, Mohamad Jawhar, Georgia Metzgeroth, Wolf-Karsten Hofmann, Daniel Nowak
Journal: Blood (2022)
Prognostic Significance of Epigenetic Modifiers Gene Mutations in Adult Acute Lymphoblastic Leukemia at Diagnosis
Authors: Jiawang Ou, Xiuli Xu, Zicong Huang, Shiyu Deng, Cai Zihong, Bingqing Tang, Xiaojie Liang, Zhengwei Wu, Yiqian Liu, Lingling Zhou, Qifa Liu, Hongsheng Zhou
Journal: Blood (2022)
Impact of Therapy on the Anamnestic Response to Seasonal Influenza Vaccination in Patients with Myeloid Malignancies
Authors: Kyle R Wiatrowski, Pragya Srivastava, Alan Hutson, Hana Golding, Surender Khurana, Lisa King, Jody Manischewitz, Molly Sheehan, Pankit Vachhani, Amanda Przespolewski, James E. Thompson, Eunice S. Wang, Michael J Nemeth, Elizabeth A. Griffiths
Journal: Blood (2022)
Predictors of Long-Term Outcome in <i>TP53</i>-Mutated Acute Myeloid Leukemia Patients Receiving Allogeneic Stem Cell Transplant after First- or Second-Line Therapy: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Authors: Talha Badar, Ehab L. Atallah, Rory Michael Shallis, Antoine N. Saliba, Maximilian F. Stahl, Jan Philipp Bewersdorf, Justin Grenet, Anand Ashwin Patel, Yasmin Abaza, Guru Subramanian Guru Murthy, Adam S Duvall, Madelyn Burkart, Neil Palmisiano, Michal Jakub Kubiak, Vamsi K. Kota, Shira Dinner, Aaron D Goldberg, Mark R. Litzow
Journal: Blood (2022)
Gimema ALL2418: Interim Analysis of a Phase Iia Study of Feasibility and Effectiveness of Inotuzumab Ozogamicin in Adult Patients with B-Cell Acute Lymphoblastic Leukemia with Positive Minimal Residual Disease before Any Hematopoietic Stem Cell Transplantation
Authors: Giovanni Marconi, Alfonso Piciocchi, Sabina Chiaretti, Cristina Papayannidis, Monia Lunghi, Prassede Salutari, Patrizia Zappasodi, Alessandro Rambaldi, Attilio Olivieri, Maurizio Cavallari, Stefano Soddu, Nicola S Fracchiolla, Federica Gigli, Chiara Cattaneo, Daniele Giovanni Mattei, Anna Candoni, Giovanni Grillo, Maria Chiara Abbenante, Ernesta Audisio, Massimiliano Bonifacio, Albana Lico, Roberto Massimo Lemoli, Paolo De Fabritiis, Felicetto Ferrara, Martina Rachele Marino, Monica Messina, Anna Ferrari, Valentina Robustelli, Jacopo Nanni, Irene Della Starza, Giorgia Simonetti, Maria Stefania De Propris, Maria Teresa Bochicchio, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood (2022)
Characteristics and Outcomes of Elderly Patients with Classical Hodgkin Lymphoma (cHL): An Australian Lymphoma Alliance (ALA), and Lymphoma and Related Disease Registry (LaRDR) Study
Authors: Zhong Goh, Maya Latimer, Katharine L. Lewis, Chan Yoon Cheah, Pietro Di Ciaccio, Tania Cushion, Eliza Hawkes, Sean Harrop, Matthew Ku, Ashlea Campbell, Nada Hamad, Erica M. Wood, Eliza Chung, Pin-Yen Chen, Tara Cochrane
Journal: Blood (2022)
Prognostic Impact of Secondary Versus De Novo Ontogeny in Acute Myeloid Leukemia (AML) Is Predominantly Accounted for By the European Leukemianet (ELN) 2022 Risk Classification
Authors: Michael J. Hochman, Megan Othus, Robert P. Hasserjian, Alexander J. Ambinder, Andrew M. Brunner, Mary-Elizabeth M. Percival, Christopher S. Hourigan, Ronan Swords, Amy E. DeZern, Elihu H. Estey, Judith E. Karp
Journal: Blood (2022)
Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China
Authors: Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, Jienan Ren, Yiping Deng, Wei Jin, Yi Feng, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang
Journal: Blood (2022)
Distinct Patterns in the Reconstitutions of Treg and T-Helper Subsets after Autologous Hematopoietic Stem Cell Transplantation in Juvenile-Onset Systemic Sclerosis Patients
Authors: Paul Szabolcs, Evelyn Garchar, Xiaohua Chen, Anwesha Sanyal, Giffin Werner, Jessie L. Barnum, Kathryn Torok
Journal: Blood (2022)
CD22-Targeted CAR-Modified T-Cells Safely Induce Remissions in Children and Young Adults with Relapsed, CD19-Negative B-ALL after Treatment with CD19-Targeted CAR T-Cells
Authors: Regina M. Myers, Amanda M. DiNofia, Yimei Li, Caroline Diorio, Richard Aplenc, Diane Baniewicz, Jennifer L Brogdon, Colleen Callahan, Boris Engels, Joseph A. Fraietta, Vanessa Gonzalez, Emma Iannone, Allison Barz Leahy, Hongyan Liu, Susan E. McClory, Susan R. Rheingold, Laura Shinehouse, Gerald Wertheim, Lisa Wray, Noelle V. Frey, Shannon L. Maude, Stephan A. Grupp
Journal: Blood (2022)
Elevated CCL22 and sIL2Rα Levels Precede the Diagnosis of Young Adult Classical Hodgkin Lymphoma: A Nested Case-Control Study from the DoD Serum Repository
Authors: Wendy Cozen, Jia Yin Wan, David V Conti, Marta Epeldegui, Yu Guo, Larry Magpantay, Ilja Nolte, Arjan Diepstra, Lynn Levin, Otoniel Martinez-Maza
Journal: Blood (2022)
Treatments and Outcomes for Patients at Academic Cancer Centers with Myelodysplastic Syndrome (MDS) By Revised International Prognostic Scoring System (IPSS-R) Scores
Authors: Connor Willis, David A. Sallman, Malinda Tan, Madeline Brendle, Vonetta L. Williams, Craig Comperatore, Trang Au, Srinivas K. Tantravahi, Najla Al Ali, Jeffrey A. Gilreath, Tibor Kovacsovics, Xiting Cao, Islam Sadek, Rami S. Komrokji, David Stenehjem
Journal: Blood (2022)
Stem Cell Mobilization Characteristics for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM) Treated with Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab (KRd-Dara)
Authors: Manisha Bhutani, Myra Robinson, Shebli Atrash, Nicole Watts, Barry Paul, Saurabh Chhabra, Neha Korde, Xhevahire Begic, David M Foureau, David J. Chung, Mauricio Pineda-Roman, Brinda Koya, Cindy Varga, Jing Ai, Natonya Daniels, Sarah Norek, Sara A Sutton, Michelle B Anderson, Ashley N Jewell, Paul W Eldridge, Donna Acampora, James T Symanowski, Luciano J. Costa, Saad Usmani, Peter M. Voorhees
Journal: Blood (2022)
Is VTD the Best First Line Therapy for Multiple Myeloma in an Environment with Limited Resources? an Analysis of Outcomes and Costs
Authors: Eliezer Tomas Tomas Gomez Gomez, David Gomez Almaguer, Cesar Homero Gutierrez-Aguirre, Perla R.R. Colunga-Pedraza, Luz Tarin-Arzaga, Jose Carlos Jaime, Edgar Ulises Coronado, Fernando De La Garza, Estefania Guadarrama Rendon, Santiago Calzada Davila
Journal: Blood (2022)
Differences in Progression and Survival Among Black Patients with Mycosis Fungoides and Sézary Syndrome: A Multicenter Retrospective Analysis at Large Urban Medical Centers
Authors: Pamela B. Allen, Subir Goyal, Swaminathan P. Iyer, Sai Talluru, Auris Huen, Irl Brian Greenwell, Jane Scribner, Shel Speegle, Tim Niyogusaba, Sunil Rangarajan, Amitkumar Mehta, Colin B. O'Leary, Anne W. Beaven, Jeffrey M. Switchenko, Amy Ayers, Safiyyah Bhatti, Shalini Krishnasamy, Pierluigi Porcu, Tarsheen Sethi, Francine M. Foss, Mary Jo Lechowicz, Sima Rozati
Journal: Blood (2022)
Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study
Authors: Patrice Chevallier, Thibault Leguay, Rathana KIM, Marc Delord, Michael Doubek, Francoise Huguet, Aurelie Cabannes-Hamy, Ulla Wartiovaara-Kautto, Colombe Saillard, Emmanuel Raffoux, Thomas Cluzeau, Stephane Lepretre, Marie Balsat, Anna Berceanu, Nicolas Boissel, Claude Gardin, Emmanuelle Clappier, Herve Dombret, Philippe Rousselot
Journal: Blood (2022)
Detection of Cell Free Tumor DNA in Plasma of Patients with Large B-Cell Lymphoma of the Sanctuary Sites By Digital Droplet PCR
Authors: Yujie Zhong, Geok Tan, Wouter J. Plattel, Johanna A.A. Bult, Nick Veltmaat, Joost L. Kluiver, Roelien Enting, Arjan Diepstra, Anke Van Den Berg, Marcel Nijland
Journal: Blood (2022)
Higher-Dose Venetoclax with Measurable Residual Disease-Guided Azacitidine Discontinuation in Newly Diagnosed Patients with Acute Myeloid Leukemia: Phase 2 Hiddav Study
Authors: Jonathan A. Gutman, Amanda C. Winters, Andrew Kent, Maria L. Amaya, Christine M. McMahon, Clayton Smith, Craig T Jordan, Brett M. Stevens, Mohammad Minhajuddin, Shanshan Pei, Jeffrey Schowinsky, Jennifer Tobin, Kelly O'Brien, Angela Falco, Elizabeth Taylor, Constance Brecl, Phuong Ho, Connor Sohalski, Jessica Dell-Martin, Olivia Ondracek, Diana Abbott, Daniel A. Pollyea
Journal: Blood (2022)
A Phase II Study of the Sequential Combination of Low-Intensity Chemotherapy (mini-hyper-CVD) and Ponatinib Followed By Blinatumomab and Ponatinib in Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
Authors: Daniel Nguyen, Elias Jabbour, Nicholas Short, Ghayas C. Issa, Musa Yilmaz, Naval Daver, Naveen Pemmaraju, Kelly S. Chien, Lucia Masarova, Farhad Ravandi, Nitin Jain, Wuliamatu Deen, Min Zhao, Christopher Loiselle, Lourdes Waller, Glenda Banks, Rebecca Garris, Hagop Kantarjian
Journal: Blood (2022)
Age ≥ 75 Years, Clinical Stage III/IV, Neutrophilia and High Lymphocyte/Monocyte Ratio Predict Decreased Overall Survival in Elderly Patients with DLBCL, NOS Older Than 70 Years
Authors: Luis Alberto de Padua Covas Lage, Rita Novello de Vita, Lucas Bassolli de Oliveira Alves, Mayara D'Auria Jacomassi, Hebert Fabricio Culler, Cadiele Oliana Reichert, Renata Oliveira Costa, Sheila Aparecida Coelho de Siqueira, Vanderson Rocha, Juliana Pereira
Journal: Blood (2022)
Blood Transfusion Ameliorates Free Haem-Induced Loss of Thrombomodulin and Endothelial Cell Activation in Paediatric Sickle Cell Anaemia
Authors: Helen Fogarty, Soracha Ward, Ellie Karampini, Azaz Ahmad, Gemma Leon, Aisling Rehill, Rosena Geoghegan, Helena Conroy, Noel Ngwenya, Mary Byrne, Ulrich Budde, Sonja Schneppenheim, Emma Tuohy, Corrina McMahon, James O'Donnell
Journal: Blood (2022)
Clinical Outcomes of CD19 CAR-T-Cell Therapy with Axi-Cel in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) with and without Prior Autologous Stem Cell Transplant
Authors: David Tong Chen, Olga Goloubeva, Hanan Alkhaldi, Aaron P. Rapoport, Saurabh Dahiya, Nancy M. Hardy, Djordje Atanackovic, Mehmet Hakan Kocoglu, Forat Lutfi, Jean A. Yared
Journal: Blood (2022)
Easix Application in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Prophylaxis
Authors: Silvia Escribano Serrat, Paola Charry, Luis Gerardo Rodríguez-Lobato, Ana Belén Moreno-Castaño, María Suárez-Lledó, Nuria Martínez-Cibrian, María Teresa Solano, Jordi Arcarons, Meritxell Nomdedeu, Joan Cid, Miquel Lozano, Alexandra Pedraza, Laura Rosiñol, Jordi Esteve, Álvaro Urbano-Ispizua, Marta Palomo, Francesc Fernández-Avilés, Maria Carmen Martinez Munoz, Maribel Diaz-Ricart, Enric Carreras, Montserrat Rovira, María Queralt Salas
Journal: Blood (2022)
Outcomes of Allogeneic Stem Cell Transplant for Multiple Myeloma
Authors: Walker M Schmidt, Francis K. Buadi, Suzanne R. Hayman, Shaji K Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q. Lacy, Prashant Kapoor, Nelson Leung, Eli Muchtar, Rahma M Warsame, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, Morie A. Gertz
Journal: Blood (2022)
Identification of Nodular Lymphocyte-Predominant Hodgkin Lymphoma Variant Morphology Using Artificial Intelligence
Authors: Siba El Hussein, Pingjun Chen, Morteza Salehjahromi, Hong Fang, Wei Wang, Sanam Loghavi, Patrick M. Reagan, Jonathan W. Friedberg, Richard Burack, Andrew G Evans, L. Jeffrey Medeiros, Jia Wu, Joseph D. Khoury
Journal: Blood (2022)
Venetoclax Plus Decitabine for Young Adults with Newly Diagnosed ELN Adverse-Risk Acute Myeloid Leukemia: Updated Results of a Phase 2 Trial
Authors: Jundan Xie, Xiaofei Yang, Xiebing Bao, Hongjie Shen, Jiannong Cen, Li Yao, Xiaohui Hu, Qian Wu, Jingren Zhang, Xuefeng He, Xiaowen Tang, AiNing Sun, Hongchun Qiu, Shengli Xue, Ying Wang, Jianhong Fu, Huiying Qiu, Depei Wu, Suning Chen
Journal: Blood (2022)
Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Kimimori Kamijo, Yoshimitsu Shimomura, Sung-Won Kim, Takahide Ara, Jun Ishikawa, Tetsuya Eto, Nobuhiro Hiramoto, Ishikazu Mizuno, Shigeru Kusumoto, Yasunori Ueda, Ken-ichi Matsuoka, Makoto Onizuka, Takahiro Fukuda, Yoshiko Atsuta, Eisei Kondo
Journal: Blood (2022)
Detection of Early Molecular Response (EMR) and Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using a Validated Next Generation Sequencing (NGS) Assay for the Detection of Tumor Variants in Circulating Tumor (ct)DNA
Authors: Renee P Stokowski, Ehsan Tabari, Patrick Bogard, Coleen Hacker, Olga K Kameneva, Tieming Ji, Li Teng, Vladislava Melnikova, Ron McCord, Elizabeth A Punnoose, Robert Loberg, Junaid Shabbeer
Journal: Blood (2022)
The Novel Role of Checkpoint Inhibitor PD-1H/VISTA in Osteoclast Cytoskeleton Regulation and Multiple Myeloma Bone Disease
Authors: Jing Fu, Shirong Li, Huihui Ma, Jun Yang, Lewis M Brown, Gabriel M. Pagnotti, Stephen J. Weiss, Markus Y. Mapara, Suzanne Lentzsch
Journal: Blood (2022)
Azacitidine Combined with Homoharringtonine, Idarubicin/Daunorubicin, Cytarabine for Previously Untreated Patients with Acute Myeloid Leukemia: A Single-Center, Phase 2 Study
Authors: Jun Li, Yanqing Huang, Yue Hou, Jie Zi, Chunhua Song, Zheng Ge
Journal: Blood (2022)
Cardiac Magnetic Resonance Predicts Heart Failure Mortality in Patients with Thalassemia Major
Authors: Antonella Meloni, Laura Pistoia, Aurelio Maggio, Roberto Mattei, Cristina Paci, Elena Facchini, Michele Santodirocco, Angela Ciancio, Silvia Macchi, Nicolò Schicchi, Emanuele Grassedonio, Vincenzo Positano, Filippo Cademartiri
Journal: Blood (2022)
Targeting S100A9 in the Inflammatory Myelodysplastic Hematopoietic Niche Reprograms the Functional Properties of CD271+ Mesenchymal Stromal Cells
Authors: Manja Wobus, Ekaterina Balaian, Triantafyllos Chavakis, Alexander Funk, Thomas Krüger, Uwe Platzbecker, Marie Törngren, Helena Eriksson, Eva Bondesson, Martin Bornhäuser, Katja Sockel
Journal: Blood (2022)